Unspecified GLP-1
Sold by Midi Health · Sublingual · every unspecified glp-1 record
What you actually pay
First month
$414
Every month after
$164
| Medication · Sublingual GLP-1, 0.075 mg | $164 |
|---|---|
| Consultation fee · first month only | $250 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Sublingual GLP-1, 0.075 mgAdvertised “Midi Compounded GLP-1 ** & GLP-1/GIP: Starts at $164 per 4-week supply, depending on medication, format, and dose. Price includes shipping and supplies, and orders ship discreetly.” source, read August 31, 2026 | Per month$164 | Charged today$164 |
We earn nothing from this link. Midi Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- August 31, 2026 — $164 · imported observation, no quote of ours
- September 2, 2026 — $164
- August 31, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Precision Compounding Pharmacy, named in the terms; the GLP-1 pricing page adds that its partner compounding pharmacies are licensed and 503A-accredited |
|---|---|
| States | All 50 states |
| Prescriber | Live visit |
| Cancellation | “You may cancel a subscription at any time by emailing support@joinmidi.com and directly requesting a cancellation, or by calling 1-888-731-8994 to cancel, or through your online account. Cancellation will take effect at the end of the current subscription period. Your subscription will automatically renew for another subscription period unless you cancel at least two (2) days before the applicable renewal processing date of your subscription.” |
| Consult fee | $250. A clinician visit is how the prescription is written, and it is priced separately from medication: $250 self-pay for the 30-minute first visit and $150 for each 15-minute follow-up, both covered for qualifying patients by most major PPO plans. This is a visit fee, not a membership; Midi's pricing page states there are no membership fees. |
Not yet checked: membership.
Recorded from joinmidi.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. August 31, 2026 — Midi Health's advertised starting price is for its sublingual medication, not its injectable — the two differ by less than $2. The headline reads: "Midi Compounded GLP-1 ** & GLP-1/GIP: Starts at $164 per 4-week supply, depending on medication, format, and dose. Price includes shipping and supplies, and orders ship discreetly." The full dose table, headed "GLP-1 Injectable 4-week supply" and "GLP-1 Sublingual 4-week supply", shows the cheapest sublingual rung at $164.00 and the cheapest injectable rung at $165.90.
- 2. August 31, 2026 — Midi Health charges $250 for a 30-minute first visit and $150 for a 15-minute returning one, and turns away Medicare, Medicaid and Medi-Cal patients outright. Visit pricing reads: "First Visit 30-minutes ... Insurance Covered Self-pay $250" and "Returning Visit 15-minutes ... Insurance Covered Self-pay $150", with "Medicare is out of network with Midi" and "We're not able to accept Medicaid or Medi-Cal patients at this time" in the same block.
- 3. August 31, 2026 — Midi's own terms disclose both its pharmacy and its support hours, at https://joinmidi.com/legals/terms-and-conditions: "Our Service provides access to prescription fulfillment services offered by the following pharmacies: Precision Compounding Pharmacy" and "Support Hours: M-F 9am - 5pm ET."
- 4. August 31, 2026 — Midi labels compounded products clearly and repeats the disclosure on both pricing surfaces: "Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are made available to patients."
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.